Correction to: Development of Nanocrystal Ziprasidone Orally Disintegrating Tablets: Optimization by Using Design of Experiment and In Vitro Evaluation
Tashan, Emine, Karakucuk, Alptug, Celebi, NevinVolume:
21
Journal:
AAPS PharmSciTech
DOI:
10.1208/s12249-020-01703-2
Date:
July, 2020
File:
PDF, 379 KB
2020